Soleno Therapeutics Inc (SLNO)

Cost of Revenue

$3.90M

TTM · Period ending: · USD

SLNO logo

SLNO Cost of Revenue

Latest reported$3.90M
SLNO TTM Cost of Revenue ($0.00 → $3.90M)
High-resolution chart · PNG

SLNO cost of revenue history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Soleno Therapeutics Inc Cost of Revenue — Trailing twelve months (TTM) (USD)
Period endingCost of Revenue (USD)
3,898,000
2,700,000
1,837,000
696,000
494,000
494,000
494,000
494,000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
819,847,000
822,536,000
822,578,000
822,787,000
3,162,306
872,306
1,258,306
1,510,306
1,544,683
1,201,683
795,683
352,683
96,000
40,000
18,000
0
0
0
0
0
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.